Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPL-01 for Postoperative Pain After Open Inguinal Herniorrhaphy
NCT05813847Phase 3Completed
- Sponsor
- Cali Pharmaceuticals
- Start
- Apr 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CPL-01 in postoperative pain, sponsored by Cali Pharmaceuticals. Started Apr 2023; status: completed.
02
Drugs
CPL-01
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05813847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05813847.